ANI Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:ANIP Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
12 Mar 24	SellUS$4,982,750	MVP Capital Partners	Company	75,000	US$67.50
11 Mar 24	SellUS$510,438	Stephen Carey	Individual	7,787	US$65.55
08 Mar 24	SellUS$2,991,469	Nikhil Lalwani	Individual	45,257	US$67.13
07 Mar 24	SellUS$1,615,313	James Marken	Individual	24,338	US$66.37
05 Mar 24	SellUS$330,000	Christopher Mutz	Individual	5,000	US$66.00
04 Mar 24	SellUS$456,400	Antonio Pera	Individual	7,000	US$65.20
14 Dec 23	SellUS$9,064,563	MVP Capital Partners	Company	174,878	US$52.72
15 Nov 23	SellUS$141,090	Krista Davis	Individual	2,622	US$53.81
10 Nov 23	SellUS$157,410	Christopher Mutz	Individual	3,000	US$52.47
29 Aug 23	SellUS$3,160,750	Esjay Llc	Company	50,000	US$63.37
23 Aug 23	SellUS$128,461	Ori Gutwerg	Individual	2,059	US$62.39
16 Aug 23	SellUS$11,700,000	MVP Capital Partners	Company	200,000	US$58.50
14 Aug 23	SellUS$181,110	Antonio Pera	Individual	3,000	US$60.37
14 Aug 23	SellUS$1,082,505	Stephen Carey	Individual	17,639	US$61.37
11 Aug 23	SellUS$3,272,462	Nikhil Lalwani	Individual	56,666	US$57.75

Insider Trading Volume

Insider Buying: ANIP insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ANIP?
Owner Type	Number of Shares	Ownership Percentage
State or Government	10,026	0.0478%
Private Companies	792,115	3.78%
Hedge Funds	1,125,000	5.36%
VC/PE Firms	1,419,381	6.77%
Individual Insiders	1,561,407	7.44%
General Public	2,528,333	12.1%
Institutions	13,544,045	64.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.1%.

Top Shareholders

Top 25 shareholders own 67.42% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12%	BlackRock, Inc.	2,524,893	US$169.8m	0.96%	no data
6.77%	MVP Capital Partners	1,419,381	US$95.5m	-13.7%	100.0%
6.14%	The Vanguard Group, Inc.	1,288,972	US$86.7m	13.8%	no data
5.36%	Rubric Capital Management LP	1,125,000	US$75.7m	32.8%	2.41%
3.73%	Esjay Llc	782,620	US$52.6m	-16.1%	no data
3.15%	Medical Strategy GmbH, Asset Management Arm	661,203	US$44.5m	-0.23%	2.57%
2.86%	Deep Track Capital, LP	600,000	US$40.3m	50%	1.3%
2.82%	State Street Global Advisors, Inc.	592,423	US$39.8m	6.65%	no data
2.82%	Dimensional Fund Advisors LP	591,731	US$39.8m	5.97%	0.01%
2.78%	Global Alpha Capital Management Ltd.	582,428	US$39.2m	10.8%	1.09%
2.34%	William Blair Investment Management, LLC	490,557	US$33.0m	-1.9%	0.04%
2.07%	Ranger Investment Management, L.P.	434,617	US$29.2m	1.82%	1.8%
1.88%	Nikhil Lalwani	394,174	US$26.5m	12.7%	no data
1.57%	Geode Capital Management, LLC	329,689	US$22.2m	2.6%	no data
1.35%	Chad Gassert	282,905	US$19.0m	-8.92%	no data
1.18%	Invesco Capital Management LLC	247,308	US$16.6m	-25.1%	0.01%
1.13%	Columbia Management Investment Advisers, LLC	236,394	US$15.9m	-4.45%	no data
1.1%	Macquarie Investment Management Business Trust	230,062	US$15.5m	0%	0.02%
1.09%	Kennedy Capital Management LLC	228,954	US$15.4m	4.99%	0.33%
1.01%	Thompson, Siegel & Walmsley LLC	212,911	US$14.3m	-6.91%	0.16%
0.96%	JP Morgan Asset Management	201,150	US$13.5m	149%	no data
0.86%	Loomis Sayles & Company, L.P.	180,429	US$12.1m	9.2%	0.02%
0.83%	Citadel Advisors LLC	173,996	US$11.7m	256%	0.01%
0.8%	Northern Trust Global Investments	167,102	US$11.2m	-1.81%	no data
0.8%	Stephen Carey	166,968	US$11.2m	7.14%	no data